Thromboembolism

Known as: Thromboembolic Event, Thromboembolic disease, Other venous embolism and thrombosis of unspecified site 
Occlusion of the lumen of a vessel by a thrombus that has migrated from a distal site via the blood stream.
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Review
2017
Review
2017
Over the last few decades, the left ventricular assist device (LVAD) technology has been tremendously improved transitioning from… (More)
  • figure 1
  • figure 2
  • figure 3
  • figure 4
  • figure 5
Is this relevant?
Review
2017
Review
2017
Takotsubo syndrome is a recently recognized acute cardiac disease entity with a clinical presentation resembling that of an acute… (More)
Is this relevant?
Highly Cited
2011
Highly Cited
2011
OBJECTIVES To evaluate the individual risk factors composing the CHADS(2) (Congestive heart failure, Hypertension, Age ≥ 75 years… (More)
Is this relevant?
Highly Cited
2011
Highly Cited
2011
BACKGROUND As trials of 5 years of tamoxifen in early breast cancer mature, the relevance of hormone receptor measurements (and… (More)
  • figure 1
  • figure 2
  • figure 3
  • figure 4
  • figure 5
Is this relevant?
Highly Cited
2009
Highly Cited
2009
PURPOSE To evaluate single-agent activity of bevacizumab in patients with recurrent glioblastoma. PATIENTS AND METHODS Patients… (More)
Is this relevant?
Highly Cited
2007
Highly Cited
2007
PURPOSE The prognosis for patients with recurrent glioblastoma multiforme is poor, with a median survival of 3 to 6 months. We… (More)
  • figure 1
  • table 1
  • figure 2
  • figure 3
  • figure 4
Is this relevant?
Highly Cited
2006
Highly Cited
2006
CONTEXT Tamoxifen is approved for the reduction of breast cancer risk, and raloxifene has demonstrated a reduced risk of breast… (More)
  • figure 1
  • table 1
  • table 2
  • figure 2
  • table 3
Is this relevant?
Highly Cited
2002
Highly Cited
2002
BACKGROUND Maintenance of sinus rhythm is the main therapeutic goal in patients with atrial fibrillation. However, recurrences of… (More)
Is this relevant?
Highly Cited
1999
Highly Cited
1999
CONTEXT Intravenous tissue-type plasminogen activator can be beneficial to some patients when given within 3 hours of stroke… (More)
Is this relevant?